PRLAX | SLAPX | PRLAX / SLAPX | |
Total Expense Ratio | 1.46 | 2.18 | 67% |
Annual Report Gross Expense Ratio | 1.46 | 2.35 | 62% |
Fund Existence | 32 years | 24 years | - |
Gain YTD | 27.665 | 33.214 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 374M | 281M | 133% |
Annual Yield % from dividends | 2.98 | 3.38 | 88% |
Returns for 1 year | 2.67 | 8.45 | 32% |
Returns for 3 years | 18.10 | 20.84 | 87% |
Returns for 5 years | 26.28 | 42.11 | 62% |
Returns for 10 years | 37.11 | 109.18 | 34% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPSX | 37.85 | 0.37 | +0.99% |
ProFunds Real Estate UltraSector Svc | |||
FIJYX | 33.12 | 0.29 | +0.88% |
Fidelity Advisor Biotechnology Z | |||
FACPX | 43.45 | -0.11 | -0.25% |
Fidelity Advisor Consumer Discret M | |||
PCAQX | 87.40 | -0.22 | -0.25% |
Principal Capital Appreciation R5 | |||
TMIFX | 11.23 | -0.06 | -0.53% |
Transamerica Mid Cap Growth R4 |